Cathie Wood Doubles Down on AI: ARK Invest Buys $2M of Tempus AI Amid Slump
Key Takeaways
- ARK Invest CEO Cathie Wood has increased her position in Tempus AI with a $2 million purchase, signaling continued conviction in AI-driven healthcare despite a 15% year-to-date decline.
- This move comes as Wood's flagship ARKK fund faces renewed pressure, trailing the S&P 500 significantly over a five-year horizon.
Mentioned
Key Intelligence
Key Facts
- 1ARK Invest purchased $2 million worth of Tempus AI (TEM) shares despite a 15% YTD decline.
- 2The flagship ARK Innovation ETF (ARKK) is down nearly 10% year-to-date as of March 13, 2026.
- 3ARKK delivered a 153% return in 2020 but has a five-year annualized return of -11%.
- 4Morningstar reports ARKK erased $7 billion in investor wealth between 2014 and 2024.
- 5Cathie Wood maintains that the AI bubble is 'years away' and the economy is a 'coiled spring'.
| Metric | ||
|---|---|---|
| 2020 Return | 153% | 18.4% |
| 2025 Return | 35.5% | 17.9% |
| 2022 Return | -60% | -18.1% |
| 5-Year Annualized Return | -11% | 12.6% |
| YTD 2026 (as of March 13) | -10% | -3% |
Who's Affected
Analysis
Cathie Wood, the high-profile CEO of ARK Investment Management, has once again demonstrated her unwavering commitment to high-conviction, high-volatility technology plays. In a move that underscores her "buy the dip" philosophy, Wood recently allocated approximately $2 million to increase ARK's position in Tempus AI Inc. (TEM). This purchase comes at a time when the AI-driven healthcare company has seen its stock price tumble by 15% year-to-date, reflecting a broader cooling of sentiment in certain segments of the artificial intelligence market. The decision to double down on Tempus AI is characteristic of Wood’s broader investment strategy, which prioritizes long-term disruptive innovation over short-term market fluctuations.
Tempus AI, which leverages machine learning and genomic data to personalize cancer treatment, fits squarely within ARK’s core investment themes: artificial intelligence, robotics, and multi-omic sequencing. Despite the recent price decline, Wood remains a vocal proponent of the stock, viewing the current valuation as an attractive entry point for a company she believes will fundamentally reshape the healthcare landscape. However, this latest move comes against a backdrop of significant underperformance for ARK’s flagship fund, the Ark Innovation ETF (ARKK). While the fund achieved legendary status in 2020 with a 153% return, its subsequent performance has been a source of intense debate among market analysts. As of mid-March 2026, ARKK is down nearly 10% year-to-date, significantly trailing the S&P 500, which has dropped only 3% in the same period.
Morningstar analyst Amy Arnott recently highlighted that between 2014 and 2024, the Ark Innovation ETF wiped out approximately $7 billion in investor wealth, ranking it as one of the most significant "wealth destroyers" among mutual funds and ETFs.
The divergence is even more stark over a five-year horizon; ARKK has delivered a five-year annualized return of -11%, while the S&P 500 has posted an annualized return of 12.6%. This performance gap has led to harsh criticism from institutional researchers. Morningstar analyst Amy Arnott recently highlighted that between 2014 and 2024, the Ark Innovation ETF wiped out approximately $7 billion in investor wealth, ranking it as one of the most significant "wealth destroyers" among mutual funds and ETFs. This data point serves as a stark reminder of the risks associated with Wood’s concentrated, high-beta approach to investing in emerging technologies. Critics argue that while her vision for the future may be accurate, the timing and valuation of her entries often leave retail investors exposed to devastating drawdowns.
What to Watch
Despite the mounting pressure and the "wealth destroyer" label, Wood remains defiant regarding the existence of an AI bubble. In her communications with investors, she has repeatedly stated that any talk of a bubble is premature, suggesting that the true transformative power of AI is still years away from being fully realized. Wood’s outlook for the U.S. economy is similarly optimistic; she recently described the current economic environment as a "coiled spring" that is storing energy for a sharp rebound in 2026. She contends that the underlying economy has suffered a "rolling recession" over the past three years, setting the stage for a powerful recovery driven by technological breakthroughs.
For institutional and retail investors alike, Wood’s latest purchase of Tempus AI serves as a litmus test for the current state of AI investment. It highlights the growing divide between those who see the recent market volatility as a necessary correction and those who view it as the beginning of a more prolonged downturn. As ARK continues to lean into its most beaten-down holdings, the performance of stocks like Tempus AI and Tesla will be critical in determining whether Wood’s "coiled spring" theory holds water or if the fund will continue to struggle against more traditional market benchmarks. The coming months will reveal if this $2 million bet is a masterstroke of contrarian investing or another contribution to the fund's historical wealth erosion.
From the Network
ARK Invest Doubles Down on Tempus AI Amid Precision Medicine Volatility
Cathie Wood's ARK Investment Management has purchased $2 million worth of Tempus AI shares, reinforcing its position in the precision medicine firm despite a 15% year-to-date decline. The move undersc
FinanceCathie Wood Doubles Down on AI with $2M Tempus AI Buy Amid Market Slump
ARK Invest CEO Cathie Wood has increased her stake in Tempus AI with a $2 million purchase, signaling continued conviction in high-growth technology despite a 15% year-to-date decline for the stock. T
Startups